Lexicon Pharmaceuticals Inc
NASDAQ:LXRX

Watchlist Manager
Lexicon Pharmaceuticals Inc Logo
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
Watchlist
Price: 1.3 USD -1.52% Market Closed
Market Cap: 472.4m USD

Intrinsic Value

The intrinsic value of one LXRX stock under the Base Case scenario is 1.01 USD. Compared to the current market price of 1.3 USD, Lexicon Pharmaceuticals Inc is Overvalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LXRX Intrinsic Value
1.01 USD
Overvaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Lexicon Pharmaceuticals Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about LXRX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is LXRX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Lexicon Pharmaceuticals Inc.

Explain Valuation
Compare LXRX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about LXRX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Lexicon Pharmaceuticals Inc

Current Assets 122.5m
Cash & Short-Term Investments 116m
Receivables 2.3m
Other Current Assets 4.2m
Non-Current Assets 83.4m
PP&E 9.5m
Intangibles 44.5m
Other Non-Current Assets 29.4m
Current Liabilities 21.7m
Accounts Payable 3.8m
Accrued Liabilities 11.8m
Other Current Liabilities 6.2m
Non-Current Liabilities 64m
Long-Term Debt 56.5m
Other Non-Current Liabilities 7.5m
Efficiency

Free Cash Flow Analysis
Lexicon Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Lexicon Pharmaceuticals Inc

Revenue
70.9m USD
Cost of Revenue
-421k USD
Gross Profit
70.4m USD
Operating Expenses
-137.3m USD
Operating Income
-66.9m USD
Other Expenses
-1.7m USD
Net Income
-68.6m USD
Fundamental Scores

LXRX Profitability Score
Profitability Due Diligence

Lexicon Pharmaceuticals Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
ROE is Increasing
Strong 3Y Average Gross Margin
27/100
Profitability
Score

Lexicon Pharmaceuticals Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

LXRX Solvency Score
Solvency Due Diligence

Lexicon Pharmaceuticals Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Negative Net Debt
46/100
Solvency
Score

Lexicon Pharmaceuticals Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LXRX Price Targets Summary
Lexicon Pharmaceuticals Inc

Wall Street analysts forecast LXRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LXRX is 2.94 USD with a low forecast of 1.01 USD and a high forecast of 6.3 USD.

Lowest
Price Target
1.01 USD
22% Downside
Average
Price Target
2.94 USD
126% Upside
Highest
Price Target
6.3 USD
385% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Lexicon Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for LXRX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

LXRX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one LXRX stock?

The intrinsic value of one LXRX stock under the Base Case scenario is 1.01 USD.

Is LXRX stock undervalued or overvalued?

Compared to the current market price of 1.3 USD, Lexicon Pharmaceuticals Inc is Overvalued by 22%.

Back to Top